PT3329019T - Utilização de il-3, il-33 e il-12p40 para caracterização de infeções respiratórias pelo vírus sincicial respiratório - Google Patents

Utilização de il-3, il-33 e il-12p40 para caracterização de infeções respiratórias pelo vírus sincicial respiratório

Info

Publication number
PT3329019T
PT3329019T PT168323863T PT16832386T PT3329019T PT 3329019 T PT3329019 T PT 3329019T PT 168323863 T PT168323863 T PT 168323863T PT 16832386 T PT16832386 T PT 16832386T PT 3329019 T PT3329019 T PT 3329019T
Authority
PT
Portugal
Prior art keywords
respiratory
characterization
syncytial
virus
infections
Prior art date
Application number
PT168323863T
Other languages
English (en)
Original Assignee
Univ Pontificia Catolica Chile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pontificia Catolica Chile filed Critical Univ Pontificia Catolica Chile
Publication of PT3329019T publication Critical patent/PT3329019T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/118Prognosis of disease development
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5403IL-3
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5434IL-12
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/12Pulmonary diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/54Determining the risk of relapse

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT168323863T 2015-07-31 2016-07-25 Utilização de il-3, il-33 e il-12p40 para caracterização de infeções respiratórias pelo vírus sincicial respiratório PT3329019T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2015002153A CL2015002153A1 (es) 2015-07-31 2015-07-31 Uso de los marcadores moleculares il-3,il33 e il-12p40 para caracterizar la severidad de infecciones respiratorias por virus respiratorio sincicial y metapneumovirus humano

Publications (1)

Publication Number Publication Date
PT3329019T true PT3329019T (pt) 2020-04-08

Family

ID=56081023

Family Applications (1)

Application Number Title Priority Date Filing Date
PT168323863T PT3329019T (pt) 2015-07-31 2016-07-25 Utilização de il-3, il-33 e il-12p40 para caracterização de infeções respiratórias pelo vírus sincicial respiratório

Country Status (17)

Country Link
US (1) US11085080B2 (pt)
EP (1) EP3329019B1 (pt)
KR (1) KR102621463B1 (pt)
CN (1) CN108368556B (pt)
AR (1) AR105542A1 (pt)
BR (1) BR112018002140B1 (pt)
CA (1) CA2994252A1 (pt)
CL (1) CL2015002153A1 (pt)
CO (1) CO2018001917A2 (pt)
ES (1) ES2783859T3 (pt)
MX (1) MX2018001373A (pt)
PE (1) PE20180577A1 (pt)
PT (1) PT3329019T (pt)
RU (1) RU2707549C2 (pt)
UY (1) UY36819A (pt)
WO (1) WO2017021814A1 (pt)
ZA (1) ZA201800940B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CR20170240A (es) 2014-11-10 2018-04-03 Genentech Inc Anticuerpos anti-interleucina-33 y sus usos
JP7231326B2 (ja) 2014-11-10 2023-03-01 ジェネンテック, インコーポレイテッド Il-33媒介性障害のための治療及び診断方法
PE20230252A1 (es) 2020-03-13 2023-02-07 Genentech Inc Anticuerpos anti-interleucina-33 y sus usos de estos
JP6960642B2 (ja) * 2020-04-16 2021-11-05 国立研究開発法人国立国際医療研究センター 呼吸器感染症の重症化の予測を補助する方法、バイオマーカーの測定値をモニタリングする方法、これらの方法に用いられる試薬キット、呼吸器感染症の重症化の予測を補助する装置およびコンピュータプログラム

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110008329A1 (en) * 2007-06-26 2011-01-13 Medlmmune, Llc Methods of Treating RSV Infections And Related Conditions
KR101286463B1 (ko) * 2011-01-28 2013-07-16 환인제약 주식회사 천궁 추출물을 함유하는 호흡기 질환의 예방 또는 치료용 조성물

Also Published As

Publication number Publication date
RU2707549C2 (ru) 2019-11-27
WO2017021814A1 (en) 2017-02-09
KR102621463B1 (ko) 2024-01-04
CN108368556A (zh) 2018-08-03
CO2018001917A2 (es) 2018-05-10
BR112018002140A2 (pt) 2018-09-11
EP3329019A1 (en) 2018-06-06
US20180327843A1 (en) 2018-11-15
ZA201800940B (en) 2019-07-31
CL2015002153A1 (es) 2016-01-29
US11085080B2 (en) 2021-08-10
RU2018104707A3 (pt) 2019-08-28
BR112018002140B1 (pt) 2024-01-23
KR20180028525A (ko) 2018-03-16
CN108368556B (zh) 2021-06-22
ES2783859T3 (es) 2020-09-18
EP3329019A4 (en) 2018-06-06
AR105542A1 (es) 2017-10-11
CA2994252A1 (en) 2017-02-09
UY36819A (es) 2017-01-31
MX2018001373A (es) 2018-06-15
RU2018104707A (ru) 2019-08-28
EP3329019B1 (en) 2020-01-01
PE20180577A1 (es) 2018-04-04

Similar Documents

Publication Publication Date Title
IL276695B (en) Antibodies, pharmaceutical preparations and their uses
ZA201604831B (en) Hybridosomes, compositions comprising the same, processes for their production and uses thereof
IL247659A0 (en) Antibodies against immunogenic glycopeptides, a preparation containing them and their use
DK3368562T3 (da) Antistof, der neutraliserer humant respiratorisk syncytialvirus
EP3385278A4 (en) Full human antibody against respiratory syncytial virus
IL257956A (en) New carbohydrate antibodies, pharmaceutical preparations and their uses
GB2588261B (en) Apparatus, use of the apparatus and arrangement
IL257340A (en) Converted benzaimidazoles, methods for their preparation and use as pharmaceuticals
IL252430A0 (en) Antibodies, uses and methods
EP3112351A4 (en) Naphthylamide compound, preparation method and use thereof
ZA201903928B (en) Compositions comprising methylphenidate-prodrugs, processes of making and using the same
IL247100A0 (en) Antibodies against cd84, preparations containing them and their uses
HUE040022T2 (hu) Eljárás (S,S)-szekoizolaricirezinol diglükozid és (R,R)-szekoizolaricirezinol diglükozid elõállítására
ZA201800940B (en) Use of il-3, il-33, and il-12p40 for characterization of the respiratory infections by syncytial respiratory virus
PL3266868T3 (pl) Heparynazy otrzymane ze Sphingobacterium daejeonense, ich wytwarzanie i ich zastosowanie
ZA201801948B (en) Compounds as stimuli-responsive probes, methods and applications thereof
ZA202004349B (en) Fluoralkenyl compounds, process for preparation and use thereof
GB2561089B (en) Process for the preparation of 17beta-hydroxy-des-a-androst-9, 10-en-5-one
PT3350150T (pt) 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização
SG11201705533SA (en) Levelling compound, its use and manufacture
RO130539B8 (ro) Compoziţie erbicidă, procedeu de preparare şi utilizarea acesteia
PL3386988T3 (pl) Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie
HUE047919T2 (hu) Biológiai asszimilációra alkalmas proteo-melanisztikus komplex, készítmény és felhasználásai
SG11201700276QA (en) Quinoxaline compounds, method for preparing the same and use thereof
PT3389858T (pt) Composição do catalisador, sua preparação e processo usando esta composição